Technical Analysis for NMRD - Nemaura Medical Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 0.00 | -99.38% | -0.03 |
Earnings due: Nov 4
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | -99.38% | |
| Fell Below 50 DMA | Bearish | -99.38% | |
| Boomer Buy Setup | Bullish Swing Setup | -99.38% | |
| Narrow Range Bar | Range Contraction | -99.38% | |
| Inside Day | Range Contraction | -99.38% | |
| Wide Bands | Range Expansion | -99.38% | |
| Gapped Down | Weakness | -99.38% | |
| 20 DMA Support | Bullish | -99.60% | |
| 50 DMA Support | Bullish | -99.60% | |
| MACD Bullish Centerline Cross | Bullish | -99.60% |
| Alert | Time |
|---|---|
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
| Fell Below Lower Bollinger Band | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 2 % | 1 day ago |
Get this analysis on your stocks daily!
- Earnings date: 11/04/2024
Nemaura Medical Inc. Description
Nemaura Medical, Inc. is a holding company. The Company owns a diagnostic medical device company specializing in discovering, developing and commercializing specialty medical devices. The Company's focus is on the development of a continuous glucose monitoring (CGM) device, which consists of a disposable patch containing a sensor, and a non-disposable miniature electronic watch with a re-chargeable power source. CGM through a non-invasive patch can enable early detection of subtle changes in blood glucose levels. The Company, through its operating subsidiaries, performs medical device research and manufacturing of a CGM, named sugarBEAT. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes, and may also be used to screen pre-diabetic patients. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm.
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Diabetes Medical Device Glucose Endocrine System Blood Test Wireless Devices Diabetes Mellitus Medical Monitoring Blood Glucose Monitoring Endocrinology Type I Diabetes Blood Sugar Level Continuous Glucose Monitor Type II Diabetes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.973 |
| 52 Week Low | 0.0292 |
| Average Volume | 10,485 |
| 200-Day Moving Average | 0.11 |
| 50-Day Moving Average | 0.04 |
| 20-Day Moving Average | 0.03 |
| 10-Day Moving Average | 0.04 |
| Average True Range | 0.01 |
| RSI (14) | 45.36 |
| ADX | 33.33 |
| +DI | 45.83 |
| -DI | 11.15 |
| Chandelier Exit (Long, 3 ATRs) | 0.03 |
| Chandelier Exit (Short, 3 ATRs) | 0.06 |
| Upper Bollinger Bands | 0.05 |
| Lower Bollinger Band | 0.02 |
| Percent B (%b) | 0.39 |
| BandWidth | 69.54 |
| MACD Line | 0.00 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0014 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.03 | ||||
| Resistance 3 (R3) | 0.03 | 0.03 | 0.03 | ||
| Resistance 2 (R2) | 0.03 | 0.03 | 0.03 | 0.03 | |
| Resistance 1 (R1) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Pivot Point | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Support 1 (S1) | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
| Support 2 (S2) | 0.03 | 0.03 | 0.03 | 0.03 | |
| Support 3 (S3) | 0.03 | 0.03 | 0.03 | ||
| Support 4 (S4) | 0.03 |
